JP Morgan Chase’s SeaStar Medical ICU Stock Holding History

JP Morgan Chase’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1	Closed	-$46	–	7535
2024 Q2	$46	Buy	+1	New	+$107	﹤0.01%	7041
2024 Q1	–	Hold	0	–	–	–	6966
2023 Q4	–	Hold	0	–	–	–	7375

Other funds holding ICU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TFS

Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

JP Morgan Chase's ICU Position: Q3 2024 in Review

JP Morgan Chase sold out of SeaStar Medical (ICU) in Q3 2024, closing a stake of 1 share — an estimated $46 sold.

JP Morgan Chase first reported a position in ICU in Q2 2024 and held it in 1 quarter. The position peaked at $46 in Q2 2024. 15 funds tracked by Wall St. Rank hold ICU as of Q3 2024.

JP Morgan Chase reported no remaining SeaStar Medical position as of Q3 2024 after selling out during the quarter.
JP Morgan Chase sold 1 SeaStar Medical share in Q3 2024, an estimated $46.
JP Morgan Chase first reported a position in SeaStar Medical in Q2 2024 and held it in 1 quarter.
JP Morgan Chase's SeaStar Medical position peaked at $46 in Q2 2024.
15 funds tracked by Wall St. Rank held SeaStar Medical as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.